Skip to main content
SpringerLink
Log in

Atypical Cystic Fibrosis and CFTR-Related Diseases

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Cystic fibrosis (CF), which is among the most common life-shortening recessive illnesses, is caused by mutations of the CF transmembrane conductance regulator (CFTR) and typically involves chronic infection and progressive obstruction of the respiratory tract as well as pancreatic exocrine insufficiency. Disease severity, to some extent, correlates with organ sensitivity to CFTR dysfunction and to the amount of functional protein, which is influenced by the type of mutation. Atypical CF represents approximately 2% of affected individuals, and includes cases presenting in adolescence or adulthood with pancreatic exocrine sufficiency, normal or borderline sweat chloride concentrations, or with a single predominant clinical feature. This review briefly describes diagnostic methods and phenotypic characteristics of classic and atypical CF, as well as CFTR-related diseases, conditions in which mutated CFTR may contribute to the pathogenesis but do not strictly fit established diagnostic criteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Strausbaugh SD, Davis PB (2007) Cystic fibrosis: a review of epidemiology and pathobiology. Clin Chest Med 28:279–288

    Article  PubMed  Google Scholar 

  2. Cystic Fibrosis Mutation Database (2007) http://www.genet.sickkids.on.ca/cftr/app

  3. Boyle MP (2003) Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 9:498–503

    Article  PubMed  Google Scholar 

  4. Rosenstein BJ, Cutting GR (1998) The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Concensus Panel. J Pediatr 132:589–595

    Article  PubMed  CAS  Google Scholar 

  5. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, Hamosh A, Cutler D, Cutting GR (2007) Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 175:1036–1043

    Article  PubMed  CAS  Google Scholar 

  6. Zielenski J (2000) Genotype and phenotype in cystic fibrosis. Respiration 67:117–133

    Article  PubMed  CAS  Google Scholar 

  7. Rosenstein BJ (1994) Genotype-phenotype correlations in cystic fibrosis. Lancet 343:746–747

    Article  PubMed  CAS  Google Scholar 

  8. Groman JD, Karczeski B, Sheridan M, Robinson TE, Fallin MD, Cutting GR (2005) Phenotypic and genetic characterization of patients with features of “nonclassic” forms of cystic fibrosis. J Pediatr 146:675–680

    Article  PubMed  Google Scholar 

  9. Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR (2002) Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 347:401–407

    Article  PubMed  CAS  Google Scholar 

  10. Mickle JE, Cutting GR (1998) Clinical implications of cystic fibrosis transmembrane conductance regulator mutations. Clin Chest Med 19:443–458 v

    Article  PubMed  CAS  Google Scholar 

  11. Noone PG, Knowles MR (2001) ‘CFTR-opathies’: disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2:328–332

    Article  PubMed  CAS  Google Scholar 

  12. Merlo CA, Boyle MP (2003) Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 141:237–241

    Article  PubMed  CAS  Google Scholar 

  13. Boyle MP (2007) Strategies for identifying modifier genes in cystic fibrosis. Proc Am Thorac Soc 4:52–57

    Article  PubMed  Google Scholar 

  14. Mishra A, Greaves R, Massie J (2007) The limitations of sweat electrolyte reference intervals for the diagnosis of cystic fibrosis: a systematic review. Clin Biochem Rev 28:60–76

    PubMed  Google Scholar 

  15. Green A, Dodds P, Pennock C (1985) A study of sweat sodium and chloride; criteria for the diagnosis of cystic fibrosis. Ann Clin Biochem 22(Pt 2):171–174

    PubMed  Google Scholar 

  16. Southern KW, Noone PG, Bosworth DG, Legrys VA, Knowles MR, Barker PM (2001) A modified technique for measurement of nasal transepithelial potential difference in infants. J Pediatr 139:353–358

    Article  PubMed  CAS  Google Scholar 

  17. Standaert TA, Boitano L, Emerson J, Milgram LJ, Konstan MW, Hunter J, Berclaz PY, Brass L, Zeitlin PL, Hammond K, Davies Z, Foy C, Noone PG, Knowles MR (2004) Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol 37:385–392

    Article  PubMed  Google Scholar 

  18. Schuler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, Hug M, Leal T, Lebacq J, Lebecque P, Lenoir G, Stanke F, Wallemacq P, Tummler B, Knowles MR (2004) Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros 3(Suppl 2):151–155

    Article  PubMed  CAS  Google Scholar 

  19. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C (2007) A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 6:57–65

    Article  PubMed  CAS  Google Scholar 

  20. Farrell MH, Farrell PM (2003) Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr 143:707–712

    Article  PubMed  Google Scholar 

  21. Orenstein DM, Rosenstein BJ, Stern RC (2000) Cystic fibrosis: medical care. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  22. Kerem E (2006) Atypical CF and CF related diseases. Paediatr Respir Rev 7(Suppl 1):S144–146

    Article  PubMed  Google Scholar 

  23. Southern KW (2007) Cystic fibrosis and formes frustes of CFTR-related disease. Respiration 74:241–251

    Article  PubMed  Google Scholar 

  24. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (1998) Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339:653–658

    Article  PubMed  CAS  Google Scholar 

  25. Pignatti PF, Bombieri C, Benetazzo M, Casartelli A, Trabetti E, Gile LS, Martinati LC, Boner AL, Luisetti M (1996) CFTR gene variant IVS8-5T in disseminated bronchiectasis. Am J Hum Genet 58:889–892

    PubMed  CAS  Google Scholar 

  26. Girodon E, Cazeneuve C, Lebargy F, Chinet T, Costes B, Ghanem N, Martin J, Lemay S, Scheid P, Housset B, Bignon J, Goossens M (1997) CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 5:149–155

    PubMed  CAS  Google Scholar 

  27. Luisetti M, Pignatti PF (2003) Genetics of idiopathic disseminated bronchiectasis. Semin Respir Crit Care Med 24:179–184

    Article  PubMed  Google Scholar 

  28. Wang X, Moylan B, Leopold DA, Kim J, Rubenstein RC, Togias A, Proud D, Zeitlin PL, Cutting GR (2000) Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 284:1814–1819

    Article  PubMed  CAS  Google Scholar 

  29. Raman V, Clary R, Siegrist KL, Zehnbauer B, Chatila TA (2002) Increased prevalence of mutations in the cystic fibrosis transmembrane conductance regulator in children with chronic rhinosinusitis. Pediatrics 109:E13

    Article  PubMed  Google Scholar 

  30. Miller PW, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR (1996) Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 59:45–51

    PubMed  CAS  Google Scholar 

  31. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG (1998) DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 351:1911–1913

    Article  PubMed  CAS  Google Scholar 

  32. King P (2007) Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 67:965–974

    Article  PubMed  CAS  Google Scholar 

  33. Rubin BK, Henke MO (2004) Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 125:70S–78S

    Article  PubMed  CAS  Google Scholar 

  34. Schechter MS (2007) Airway clearance applications in infants and children. Respir Care 52:1382–1390 discussion 1390–1381

    PubMed  Google Scholar 

  35. Wills P, Greenstone M (2006) Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev CD002996

  36. Rubin BK (2006) Other medications for aerosol delivery. Paediatr Respir Rev 7(Suppl 1):S76–79

    Article  PubMed  Google Scholar 

  37. Akai S, Okayama H, Shimura S, Tanno Y, Sasaki H, Takishima T (1992) Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan. Am Rev Respir Dis 146:781–783

    PubMed  CAS  Google Scholar 

  38. Poletti V, Casoni G, Chilosi M, Zompatori M (2006) Diffuse panbronchiolitis. Eur Respir J 28:862–871

    Article  PubMed  CAS  Google Scholar 

  39. Knowles MR, Durie PR (2002) What is cystic fibrosis? N Engl J Med 347:439–442

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eudowood Division of Pediatric Respiratory Sciences, The Johns Hopkins University, David M. Rubenstein Child Health Building, 200 North Wolfe Street, Baltimore, MD, 21287, USA

    Shruti M. Paranjape & Pamela L. Zeitlin

Authors
  1. Shruti M. Paranjape
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pamela L. Zeitlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pamela L. Zeitlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paranjape, S.M., Zeitlin, P.L. Atypical Cystic Fibrosis and CFTR-Related Diseases. Clinic Rev Allerg Immunol 35, 116–123 (2008). https://doi.org/10.1007/s12016-008-8083-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-008-8083-0

Keywords

Search

Navigation